newsfilter
← Latest News
GlobeNewswire·

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

DALLAS, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ("Instil" or the "Company") (NASDAQ:TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for